Detalhe da pesquisa
1.
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.
Am J Pathol
; 186(12): 3131-3145, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27770613
2.
Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor.
Am J Pathol
; 181(5): 1642-58, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22982188
3.
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Mol Cancer Res
; 16(4): 682-695, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29453322
4.
Mouse modeling in oncologic preclinical and translational research.
Clin Cancer Res
; 12(18): 5305-11, 2006 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17000663
5.
A metabolic prosurvival role for PML in breast cancer.
J Clin Invest
; 122(9): 3088-100, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22886304
6.
Effects of promyelocytic leukemia protein on virus-host balance.
J Virol
; 76(8): 3810-8, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-11907221
7.
Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
J Biol Chem
; 279(34): 35139-49, 2004 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-15151996